Similar articles

• Chemotherapy for osteogenic sarcoma: an investigative method, not a recipe.

  Rosen G, Nirenberg A. Rosen G, et al. Cancer Treat Rep. 1982 Sep;66(9):1687-97. Cancer Treat Rep. 1982. PMID: 6981454 No abstract available.
• Adjuvant methotrexate and citrovorum-factor treatment of osteogenic sarcoma.

  Jaffe N, Frei E 3rd, Traggis D, Bishop Y. Jaffe N, et al. N Engl J Med. 1974 Nov 7;291(19):994-7. doi: 10.1056/NEJM197411072911902. N Engl J Med. 1974. PMID: 4606174 Clinical Trial. No abstract available.
• Osteosarcoma in adolescents and young adults: new developments and controversies. The Childrens Cancer Group (CCG) studies.

  Miser JS, Krailo M. Miser JS, et al. Cancer Treat Res. 1993;62:287-91. Cancer Treat Res. 1993. PMID: 7682089 Clinical Trial. No abstract available.
• [Progress and stagnation in chemotherapy protocols for primary osteosarcoma].

  Delépine N, Alkallaf S, Cornille H, Markowska B, Delépine G. Delépine N, et al. Ann Med Interne (Paris). 2003 Feb;154(1):12-24. Ann Med Interne (Paris). 2003. PMID: 12746655 Review. French.
• Osteosarcoma in adolescents and young adults: new developments and controversies. The Mayo Clinic studies.

  Miser JS, Pritchard DJ, Rock MG, Shives TC, Gilchrist GS, Smithson WA, Arndt CA, Edmonson JH, Schaid DJ. Miser JS, et al. Cancer Treat Res. 1993;62:333-8. Cancer Treat Res. 1993. PMID: 8096748 Review. No abstract available.